Seroepidemiology of Varicella Zoster Virus among children, adolescents and medical students in a referral children medical center, Tehran, Iran
-
B Pourakbari
,
L Shahbaznezhad
,
N Parvaneh
,
S Nikkhah
,
S Mahmoudi
,
M Teymuri
,
Ae Alyari
,
S Mamishi
Abstract
Background and Objective: Varicella is a benign childhood infection with considerable complication in none immune adults. The aim of this study was to survey Varicella Zoster Virus (VZV) seroepidemiology in children, adolescents and medical students in Children Medical Center, Tehran, Iran.
Material and Methods: In this cross sectional study, serum sample of children, adolescents 10 to 18 years old and medical students 18 to 25 years old were tested for VZV IgG with a commercial ELISA kit.
Results: A total of 412 individuals who were 10 to 25 years of age participated in this study. Overall 269 individuals (65.3%) were seropositive for VZV IgG. Seroprevalence of VZV antibody increased with age of participants, from 59% in 10-11years children to 80% in 20-21 years old young adult students, except in 22-23 and 24-25 years old, whom the frequency of positive results decreased interestingly to 41.7 and 52.8%, respectively. Prevalence of positive VZV antibody between two genders was not statistically different.
Conclusion: On-going monitoring of the seroepidemilogy of VZV is necessary to assess trends of infection in the community. A considerable proportion of young medical students in this study were still susceptible to VZV and consequent complications.
Heininger U, Seward JF. Varicella. Lancet 2006; 368 (9544): 1365-1376.
Cameron JC, Allan G, Johnston F, Finn A, Heath PT, Booy R. Severe complications of chickenpox in hospitalised children in the UK and Ireland. Arch Dis Child 2007; 92: 1062-1066.
Persson A, Bergström T, Lindh M, Namvar L, Studahl M.Varicella-zoster virus CNS disease-Viral load, clinical manifestations and sequels. J Clin Virol 2009;46: 249-253.
Liese JG, Grote V, Rosenfeld E, Fischer R, Belohradsky BH, v Kries R, ESPED Varicella Study Group: The burden of varicella complications before the introduction of routine varicella vaccination in Germany. Pediatr Infect Dis J 2008; 27: 119-124.
Hambleton S, Gershon AA. Preventing Varicella-Zoster Disease. Clin Microbiol Rev 2005; 18: 70-80.
CDC. Varicella-related deaths among adults-United States, 1997. MMWR 1997; 46: 410-412.
Institute for Clinical Evaluative Sciences. A disease most fowl: an update on the varicella zoster virus.Informed 1999; 5: 1-3, 8.
Socan M, Berginc N, Lajovic J. Varicella susceptibility and transmission dynamics in Slovenia. BMC Public Health. 2010; 10: 360.
Glantz JC, Mushlin AI. Cost-effectiveness of routine antenatal varicella screening. Obstet Gynecol 1998; 91:519-28.
Amanna IJ, Carlson NE, Slifka MK. Duration of Humoral Immunity to Common Viral and Vaccine Antigens. N Engl J Med 2007; 357: 1903-1915.
Sharifi Z, Emadi Ghanjin S. The seroepidemiology of Varicella Zoster Virus (VZV) in different age groups in Tehran, Iran. Iran J Allergy Asthma Immunol 2005; 4:95-98.
Ziyaeyan M, Alborzi A, Jamalidoust M, Moieni M, Pourabbas B. Seroepidemiology of Varicella Zoster Virus Infection among 1-70 year individuals in Iran. IRCMJ 2010; 12: 176-180.
Choi WS, Noh JY, Huh JY, Jo YM, Lee J, Song JY, et al. Seroprevalence of varicella-zoster virus in Korea. J Med Virol. 2010 Dec; 82: 2123-2126.
Lafer MM, de Moraes-Pinto MI, Weckx LY. Prevalence of IgG varicella zoster virus antibodies in the Kuikuro and Kaiabi indigenous communities in Xingu National Park, Brazil, before varicella vaccination. Rev Inst Med Trop Sao Paulo 2005; 47: 139-142.
Alp H, Altinkaynak S, Ertekin V, Kiliçaslan B, Giiraksin A. Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey. Health Policy 2005; 72: 119-124.
Akram DS, Qureshi H, Mahmud A, Khan AA, Kundi Z, Shafi S, et al. Seroepidemiology of varicella-zoster in Pakistan. Southeast Asian J Trop Med Public Health 2000; 31: 646-649.
Tseng HF, Tan HF, Chang CK, Wang LY, Yang SE, Liau MY, et al. A seroepidemiology study of varicella among children aged 0-12 years in Taiwan. Southeast Asian J Trop Med Public Health 2005; 36: 1201-1207. 18. Clemens SA, Azevedo T, Fonseca JC, Silva AC, Silveira TR, Clemens R. Soroepidemiology of Varicella in Brazil - results of a prospective cross-sectional study. J Pediatr (Rio J) 1999; 75: 433-441.
Farshchi A, Niayesh A. seroprevalence of Varicella antibodies in healthcare workers in Imam Reza hospital of Kermanshah-Iran. JPHS 2011; 1: 37-40.
Talebi-Taher M, Noori M, Shamshiri AR, Barati M.Varicella Zoster antibodies among health care workers in a university hospital, Teheran, Iran. Int J Occup Med Environ Health 2010; 23: 27-32.
Wicker S, Rabenau HF, Gottschalk R, Doerr HW,Allwinn R. Seroprevalence of vaccine preventable and bloodtransmissible viral infections (measles, mumps, rubella, polio, HBV, HCV and HIV) in medical students. Med Microbiol Immunol 2007; 196: 145-150.
Baer G, Bonhoeffer J, Schaad UB, Heininger U.Seroprevalence and immunization history of selected vaccine preventable diseases in medical students. Vaccine 2005; 23: 2016-2020.
| Files | ||
| Issue | Vol 4 No 3 (2012) | |
| Section | Articles | |
| Keywords | ||
| Adolescents Children Medical students Seroepidemiology Varicella Zoster Virus | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
